在诱导器性失声症中注射肉毒素的结果
S M Tanjil-Ul-Alam1, S Sohel, S Talukdar
1Dr Sheikh Mohammad Tanjil-Ul-Alam, Assistant Registrar, Deparment of ENT & Head-Neck Surgery, Sir Salimullah Medical College & Mitford Hospital, Dhaka, Bangladesh;
Mymensingh medical journal : MMJ
|September 30, 2025
概括
毒素注射显著改善了诱导器性失声症,在注射后2周和8周观察到声音的改善. 轻微的并发症很快就会消失,但大约每12周需要重复治疗一次.
科学领域:
- 耳鼻喉科-头部和部手术
- 神经学 神经学
- 语音语言病理学 语言病理学
背景情况:
- 诱导性性失声症 (AdSD) 是一种声音障碍,通常用肉毒素注射来治疗.
- 毒素对ADSD的疗效,持续时间和并发症需要持续调查.
研究的目的:
- 为了评估毒素 (BoNT) 注射在患有诱导器性失声症的患者的结果.
- 在注射后的不同时间点使用语音障碍指数 (VHI) 评估语音障碍的变化.
主要方法:
- 这是一项前性,单臂干预性研究,涉及34名AdSD患者.
- 语音障碍指数 (VHI) 评分 (功能,身体,情绪,总) 记录在注射前和注射后1-3天,2周,8周和12周.
- 统计分析比较了注射前和注射后的VHI得分.
主要成果:
- 在注射后2周 (总VHI变化:48.53) 和8周 (总VHI变化:31.89) 观察到VHI得分的统计学显著改善 (p <0.05).
- 在注射后1-3天或12周内没有发现显著的VHI改善.
- 并发症是轻微的和短暂的,在1-4天内消失.
结论:
- 毒素注射可显著改善助性性失声症患者的声音.
- 这些有益的效果需要大约每12周进行一次重复治疗以保持持续的语音质量.
- 进一步的研究可能会探索最佳的剂量和注射间隔.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
913
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
913
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Skeletal Muscle Relaxants: Adverse Effects
776
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
776
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Depolarizing Blockers: Pharmocokinetics
567
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
567
Depolarizing Blockers: Mechanism of Action
2.7K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.7K


